Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 72 results.
User Information
Export Records
  1. 1.   Histidine Tag-Specific PEGylation Improves the Circulating Half-Life of TIMP2
  2. Toor, Jack; Grabowska, Wiktoria R; Johnson, Adam L; Jones,Jane; Stetler-Stevenson, William G; Khalili, Hanieh; Peeney, David
  3. ACS Applied Bio Materials. 2025, Feb 21;
  1. 2.   Unraveling the dynamics of B7-H3-targeting therapeutic antibodies in cancer through PET imaging and antibody pharmacokinetics
  2. Fernandes, Bruna; Olkowski, Colleen P; Ghaemi, Behnaz; Basuli, Falguni; Shi, Jianfeng; Kiesewetter, Dale O; Lang, Lixin; Elijah, Edmondson; Swenson, Rolf; Choyke, Peter L; Lin, Frank I; Jacobson, Orit
  3. Journal of Controlled Release : official journal of the Controlled Release Society. 2025, Jan 13;
  1. 3.   Nano-mupirocin as tumor-targeted antibiotic: Physicochemical, immunotoxicological and pharmacokinetic characterization, and effect on gut microbiome
  2. Cern, Ahuva; Skoczen,Sarah; Snapp, Kelsie S; Hod, Atara; Zilbersheid, Daniel; Bavli, Yaelle; Alon-Maimon, Tamar; Bachrach, Gilad; Wei, Xiaohui; Berman, Bella; Yassour, Moran; Cedrone,Edward; Neun,Barry; Dobrovolskaia,Marina; Clogston,Jeffrey; Stern,Steve; Barenholz, Yechezkel
  3. Journal of Controlled Release : official journal of the Controlled Release Society. 2024, Aug 2; 373: 713-726.
  1. 4.   Distinct uptake and elimination profiles for trastuzumab, human IgG and biocytin-TMR in experimental HER2+ brain metastases of breast cancer
  2. Silvestri, Vanesa L; Tran, Andy D; Chung, Monika; Chung, Natalie; Gril, Brunilde; Robinson,Christina; Difilippantonio,Simone; Wei, Debbie; Kruhlak, Michael J; Peer, Cody J; Figg, W Douglas; Khan, Imran; Steeg, Patricia S
  3. Neuro-Oncology. 2024, Feb 13;
  1. 5.   Viral dissemination and immune activation modulate antiretroviral drug levels in lymph nodes of SIV-infected rhesus macaques
  2. Srinivasula,Sharat; Degrange, Paula; Perazzolo, Simone; Bonvillain, Andrew; Tobery, Amanda; Kaplan, Jacob; Jang, Hyukjin; Turnier, Refika; Davies, Michael; Cottrell, Mackenzie; Ho, Rodney J Y; Di Mascio, Michele
  3. Frontiers in Immunology. 2023, Sep 18; 14: 1213455.
  1. 6.   A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer
  2. Manzo, Julia; Puhalla, Shannon; Pahuja, Shalu; Ding, Fei; Lin, Yan; Appleman, Leonard; Tawbi, Hussein; Stoller, Ronald; Lee, James J; Diergaarde, Brenda; Kiesel, Brian F; Yu, Jing; Tan, Antoinette R; Belani, Chandra P; Chew, Helen; Garcia, Agustin A; Morgan, Robert J; Wahner Hendrickson, Andrea E; Visscher, Daniel W; Hurley, Rachel M; Kaufmann, Scott H; Swisher, Elizabeth M; Oesterreich, Steffi; Katz, Tiffany; Ji,Jay; Zhang, Yiping; Parchment, Ralph E; Chen, Alice; Duan, Wenrui; Giranda, Vincent; Shepherd, Stacie P; Ivy, S Percy; Chu, Edward; Beumer, Jan H
  3. Cancer Chemotherapy and Pharmacology. 2022, Apr 18; 89(5): 721-735.
  1. 7.   Bioequivalence assessment of high-capacity polymeric micelle nanoformulation of paclitaxel and Abraxane (R) in rodent and non-human primate models using a stable isotope tracer assay
  2. Hwang, Duhyeong; Vinod, Natasha; Skoczen,Sarah; Ramsey, Jacob D.; Snapp,Kelsie; Montgomery, Stephanie A.; Wang, Mengzhe; Lim, Chaemin; Frank, Jonathan E.; Sokolsky-Papkov, Marina; Li, Zibo; Yuan, Hong; Kabanov, Alexander; Stern,Steve
  3. Biomaterials . 2021, Nov; 278
  1. 8.   Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
  2. LeBlanc, Amy K.; Mazcko, Christina N.; Cherukuri, Aswini; Berger,Erika; Kisseberth, William C.; Brown, Megan E.; Lana, Susan E.; Weishaar, Kristen; Flesner, Brian K.; Bryan, Jeffrey N.; Vail, David M.; Burton, Jenna H.; Willcox, Jennifer L.; Mutsaers, Anthony J.; Woods, J. Paul; Northrup, Nicole C.; Saba, Corey; Curran, Kaitlin M.; Leeper, Haley; Wilson-Robles, Heather; Wustefeld-Janssens, Brandan G.; Lindley, Stephanie; Smith, Annette N.; Dervisis, Nikolaos; Klahn, Shawna; Higginbotham, Mary Lynn; Wouda, Raelene M.; Krick, Erika; Mahoney, Jennifer A.; London, Cheryl A.; Barber, Lisa G.; Balkman, Cheryl E.; McCleary-Wheeler, Angela L.; Suter, Steven E.; Martin, Olya; Borgatti, Antonella; Burgess, Kristine; Childress, Michael O.; Fidel, Janean L.; Allstadt, Sara D.; Gustafson, Daniel L.; Selmic, Laura E.; Khanna, Chand; Fan, Timothy M.
  3. CLINICAL CANCER RESEARCH. 2021, Jun 1; 27: 3005-3016.
  1. 9.   Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors
  2. Takebe, Naoko; Coyne, Geraldine O'Sullivan; Kummar, Shivaani; Collins, Jerry; Reid, Joel M; Piekarz, Richard; Moore, Nancy; Juwara, Lamin; Johnson,Barry; Bishop, Rachel; Lin, Frank I; Mena, Esther; Choyke, Peter L; Lindenberg, M Liza; Rubinstein, Larry V; Bonilla, Cecilia Monge; Goetz, Matthew P; Ames, Matthew M; McGovern, Renee M; Streicher, Howard; Covey, Joseph M; Doroshow, James H; Chen, Alice P
  3. Oncotarget. 2021, Feb 16; 12(4): 268-277.
  1. 10.   Predicting Volume of Distribution in Humans: Performance of in silico Methods for A Large Set of Structurally Diverse Clinical Compounds
  2. Murad, Neha; Pasikanti, Kishore K; Madej,Benjamin; Minnich, Amanda; McComas, Juliet M; Crouch, Sabrinia; Polli, Joseph W; Weber, Andrew D
  3. Drug metabolism and disposition: the biological fate of chemicals. 2021, Feb 1; 49: 169-178.
  1. 11.   Safety and Stability of Antibody-Dye Conjugate in Optical Molecular Imaging
  2. Pei, Jacqueline; Juniper, Georgina; van den Berg, Nynke S.; Nisho, Naoki; Broadt,Trevor; Welch,Anthony; Yi, Grace S.; Raymundo, Roan C.; Chirita, Stefania U.; Lu, Guolan; Krishnan, Giri; Lee, Yu-Jin; Kapoor, Shrey; Zhou, Quan; Colevas, A. Dimitrios; Lui, Natalie S.; Poultsides, George A.; Li, Gordon; Zinn, Kurt R.; Rosenthal, Eben L.
  3. MOLECULAR IMAGING AND BIOLOGY. 2020, SEP 3;
  1. 12.   LC-MS/MS assay coupled with carboxylic acid magnetic bead affinity capture to quantitatively measure cationic host defense peptides (HDPs) in complex matrices with application to preclinical pharmacokinetic studies
  2. O'Neill,Maura; Chan,King; Jaynes, Jesse M; Knotts, Zachary; Xu,Xia; Abisoye-Ogunniyan, Abisola; Guerin,Theresa; Schlomer,Jerome; Li, Dandan; Cary, Jeffrey W; Rajasekaran, Kanniah; Yates, Clayton; Kozlov,Serguei; Andresson,Thorkell; Rudloff, Udo
  3. Journal of pharmaceutical and biomedical analysis. 2020, Mar 20; 181: 113093.
  1. 13.   Heterogeneous antiretroviral drug distribution and HIV/SHIV detection in the gut of three species
  2. Thompson, Corbin G; Rosen, Elias P; Prince, Heather M A; White, Nicole; Sykes, Craig; de la Cruz, Gabriela; Mathews, Michelle; Deleage,Claire; Estes,Jake; Charlins, Paige; Mulder, Leila R; Kovarova, Martina; Adamson, Lourdes; Arora, Shifali; Dellon, Evan S; Peery, Anne F; Shaheen, Nicholas J; Gay, Cynthia; Muddiman, David C; Akkina, Ramesh; Victor Garcia, J; Luciw, Paul; Kashuba, Angela D M
  3. Science translational medicine. 2019, Jul 03; 11(499): pii: eaap8758..
  1. 14.   Population Pharmacokinetics and Pharmacodynamics of Disulfiram on Inducing Latent HIV-1 Transcription in a Phase 2b Trial
  2. Lee, Sulggi A; Elliott, Julian H; McMahon, James; Hartogenesis, Wendy; Bumpus, Namandje N; Lifson, Jeffrey; Gorelick, Robert; Bacchetti, Peter; Deeks, Steven G; Lewin, Sharon R; Savic, Radojka M
  3. Clinical pharmacology and therapeutics. 2019, Mar; 105(3): 692-702.
  1. 15.   Disruption of the Rbm38-eIF4E Complex with a Synthetic Peptide Pep8 Increases p53 Expression
  2. Lucchesi, Christopher A.; Zhang, Jin; Ma, Buyong; Chen, Mingyi; Chen, Xinbin
  3. CANCER RESEARCH. 2019, FEB 15; 79(4): 807-818.
  1. 16.   Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-Kras(G12D/+);Tp53(R172H/+) (KPC) mice, a genetically engineered model of pancreatic cancer
  2. Vilimas, Tomas; Wang, Amy Q.; Patnaik, Samarjit; Hughes, Emma A.; Singleton, Marc D.; Knotts, Zachary; Li, Dandan; Frankowski, Kevin; Schlomer, Jerome; Guerin, Theresa; Springer, Stephanie; Drennan, Catherine; Dextras, Christopher; Wang, Chen; Gilbert, Debra; Southall, Noel; Ferrer, Marc; Huang, Sui; Kozlov, Serguei; Marugan, Juan; Xu, Xin; Rudloff, Udo
  3. CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2018, Dec; 82(6): 1067-1080.
  1. 17.   Optimized administration of hetIL-15 expands lymphocytes and minimizes toxicity in rhesus macaques
  2. Bergamaschi, Cristina; Watson, Dennis; Valentin, Antonio; Bear, Jenifer; Peer, Cody J; Figg, William D; Felber, Barbara; Pavlakis, George
  3. Cytokine. 2018, Aug; 108: 213-224.
  1. 18.   First-in-human study of the epichaperome inhibitor PU-H71: clinical results and metabolic profile
  2. Speranza, Giovanna; Anderson, Larry; Chen, Alice P; Do, Khanh; Eugeni, Michelle; Weil, Marcie; Rubinstein, Larry; Majerova, Eva; Collins, Jerry; Horneffer, Yvonne; Juwara, Lamin; Zlott, Jennifer; Bishop, Rachel; Conley, Barbara A; Streicher, Howard; Tomaszewski, Joseph; Doroshow, James H; Kummar, Shivaani
  3. Investigational New Drugs. 2018, Apr; 36(2): 230-239.
  1. 19.   Pharmacokinetics of dacarbazine (DTIC) in pregnancy
  2. Kantrowitz-Gordon, Ira; Hays, Karen; Kayode, Olumide; Kumar, Aditya R.; Kaplan, Henry G.; Reid, Joel M.; Safgren, Stephanie L.; Ames, Matthew M.; Easterling, Thomas R.; Hebert, Mary F.
  3. Cancer Chemotherapy and Pharmacology. 2018, Mar; 81(3): 455-460.
  1. 20.   Differential Influence of the Antiretroviral Pharmacokinetic Enhancers Ritonavir and Cobicistat on Intestinal P-Glycoprotein Transport and the Pharmacokinetic/Pharmacodynamic Disposition of Dabigatran
  2. Kumar, Parag; Gordon, Lori A.; Brooks, Kristina M.; George, Jomy M.; Kellogg, Anela; McManus, Maryellen; Alfaro, Raul M.; Nghiem, Khanh; Lozier, Jay; Hadigan, Colleen; Penzak, Scott R.
  3. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2017, NOV; 61(11):
  1. 21.   Decreased Absorption of Dolutegravir and Tenofovir Disoproxil Fumarate, But Not Emtricitabine, in an HIV-Infected Patient Following Oral and Jejunostomy-Tube Administration
  2. Brooks, Kristina M.; Garrett, Katy L.; Kuriakose, Safia; George, Jomy M.; Balba, Gayle; Bailey, Bria; Anderson, Megan; Lane, H. Clifford; Maldarelli, Frank; Pau, Alice K.
  3. Pharmacotherapy. 2017, Aug; 37(8): E82-E89.
  1. 22.   Parent-Metabolite Pharmacokinetic Modeling and Pharmacodynamics of Veliparib (ABT-888), a PARP Inhibitor, in Patients With BRCA 1/2-Mutated Cancer or PARP-Sensitive Tumor Types
  2. Niu, Jing; Scheuerell, Christie; Mehrotra, Shailly; Karan, Sharon; Puhalla, Shannon; Kiesel, Brian F; Ji, Jay; Chu, Edward; Gopalakrishnan, Mathangi; Ivaturi, Vijay; Gobburu, Jogarao; Beumer, Jan H
  3. Journal of clinical pharmacology. 2017, Aug; 57(8): 977-987.
  1. 23.   Genome-wide analysis of clopidogrel active metabolite levels identifies novel variants that influence antiplatelet response
  2. Backman, Joshua D.; O'Connell, Jeffrey R.; Tanner, Keith; Peer, Cody J.; Figg, William D.; Spencer, Shawn D.; Mitchell, Braxton D.; Shuldiner, Alan R.; Yerges-Armstrong, Laura M.; Horenstein, Richard B.; Lewis, Joshua P.
  3. PHARMACOGENETICS AND GENOMICS. 2017, Apr; 27(4): 159-163.
  1. 24.   Antiretroviral Boosting Agent Cobicistat Increases the Pharmacokinetic Exposure and Anticoagulant Effect of Dabigatran in HIV-Negative Healthy Volunteers.
  2. Gordon, Lori A; Kumar, Parag; Brooks, Kristina M; Kellogg, Anela; McManus, Maryellen; Alfaro, Raul M; Nghiem, Khanh; George, Jomy M; Lozier, Jay; Penzak, Scott R; Hadigan, Colleen
  3. Circulation. 2016, Dec 6; 134(23): 1909-1911.
  1. 25.   Prediction of pharmacokinetic and toxicological parameters of a 4-phenylcoumarin isolated from geopropolis: in silico and in vitro approaches
  2. da Cunha, M. G.; Franco, G. C.; Franchin, M.; Beutler, John; de Alencar, S. M.; Ikegaki, M.; Rosalen, P. L.
  3. Toxicology Letters. 2016, Nov 30; 263: 6-10.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel